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Antimicrobial activityAbstract A novel Schiff base ligand, N,N0-bis (glyoxalicacidcarboxaldiimine)-1,8-diaminonaph-
thalene [H2L] obtained by the condensation of glyoxalic acid and 1,8-diaminonaphthalene and
its mononuclear complexes of type, [ML] [M = Co(II), Ni(II), Cu(II), Zn(II)] have been synthesized
and characterized on the basis of elemental analysis, molar conductance, magnetic susceptibility
measurements and spectroscopic studies viz., FT-IR, EPR, 1H NMR, FAB-Mass, UV–vis and mag-
netic moment data. A square planar geometry has been assigned on the basis of UV–vis and mag-
netic susceptibility around Co(II), Ni(II) and Cu(II) ions while conductivity data showed non
electrolytic nature of all the complexes. The synthesized ligand, H2L and its complexes have been
tested against Streptococcus mutans, Staphylococcus pyogenes, MRSA (Gram positive bacteria),
Pseudomonas aeruginosa, Salmonella typhimurium, Escherichia coli (Gram negative bacteria),
Candida albicans, Candida krusei, Candida parapsilosis and Candida neroformans and results
suggested that Cu(II) complex has signiﬁcant antimicrobial activity.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Schiff base ligands have played an integral and important role
in the development of coordination chemistry since the late
19th century. Metal complexes of these ligands are ubiquitous
due to their facile synthesis, wide applications and the accessi-
bility of diverse structural modiﬁcations (Coles et al., 1998).
336 S.I. Al-Resayes et al.The chemistry of Schiff base ligands and their metal complexes
has expanded enormously and encompasses a vast area of
organometallic compounds and various aspects of bioinor-
ganic chemistry (Yamada, 1999). Their chelating structures,
moderate electron donation and easy tunable electronic and
steric effects also make Schiff bases as versatile ligands capable
of stabilizing different metals in various oxidation states with
unusual structural features and controlling the performance
of metals in a variety of useful catalytic transformations
(Cozzi, 2004; Garnoviskii et al., 1993; Makio et al., 2002;
Mcmurry, 1989; Atwood and Harrey, 2001; Gansauer and
Bluhm, 2000). Characteristically, Schiff base provides geomet-
rical cavity control for host–guest interaction and modulation
of its lipophilicity offers remarkable selectivity, sensitivity and
stability for a speciﬁc metal ion. It has been observed that most
of the metals make 1:1 metal complexes with Schiff bases
(Jacobsen et al., 1999). Among the inorganic mimics of en-
zymes, metal complexes containing porphyrin, salen and
phthalocyanine ligands have been investigated as possible
alternative catalysts in many oxidation and hydroxylation
reactions (Kim et al., 2007; Raja and Ratnasamy, 1996; Jacob
et al., 1998; Lu et al., 2006; Fukuda and Katsuki, 1997, 1993b,
1995c, 1997d; Li et al., 1993; Yamashita and Katsuki, 1995;
Tokunaga et al., 1997). It has been suggested that the azome-
thine linkage is responsible for the biological activities such as
in the treatment of cancer (Yu et al., 1993), as antibactericide
(Wang et al., 2001) as antivirus agent (Tarasoni et al., 2000;
Singh et al., 1981) and other biological properties (Charo
et al., 2004). Several applications have been related for these
complexes in chemical analysis, absorption and transport of
oxygen, in pesticides and heterogenous and homogenous catal-
ysis for oxidation and polymerization of organic compounds
(Kanthimathi et al., 2000; Zhang et al., 2006; Bahramian
et al., 2006). Transition metal complexes containing oxygen
and nitrogen donor Schiff base ligands have been of research
interest for many years (Krishnaraj et al., 2008). The metals
in these complexes act as active sites and thereby catalyse
chemical reactions (Sheldon and Kochi, 1981). Antimicrobial
diseases are now more frequent than during the ﬁrst half of
the century, being still difﬁcult to diagnose clinically. During
the later half of the century, particularly during the past
two decades, a number of different classes of antibacterial
(Appelbaum and Hunter, 2000) antifungal agents (Brickner
et al., 1996; Andriole et al., 1998) have been discovered. At
the present time, antibacterial sulfa drugs, nitrofuranes,
penicillins, cephalosporins, tetracyclines, macrolides and oxao-
lidinones and antifungal agents such as ﬂuconazole, ketocona-
zole and miconazole, including amphotericin B exhibit their
antimicrobial activity (Appelbaum and Hunter, 2000; Current
et al., 1995; Snaz-Nebot et al., 1995; Vazquez et al., 1998).
Although there has been much progress in antibacterial and
antifungal therapies many problems remain to be solved for
most antimicrobial drugs available. For example, although
amphotericin B has strong antifungal activity its serious neph-
rotoxicity often limits its clinical application (Fanos and
Cataldi, 2000). Fungal infections are not usually limited to the
superﬁcial tissues. Indeed, a signiﬁcant increase in life threaten-
ing systemic fungal infections has been reported (Sundriyal
et al., 2006). The fundamental reason for this is the increasing
number of patients at risk, including those with advanced age,
major surgery, immunosuppressive therapy, acquired immuno-
deﬁciency syndrome (AIDS), cancer treatment and solid-organand hematopoietic stem cell transplantation (Nucci and Marr,
2005). The search and development of more effective antifungal
agents are mandatory (Martins et al., 2009a,b) and some Schiff
bases are known to be promising antifungal agents.
However, a few reports appeared on Schiff base complexes
derived from glyoxalic acid involving thiosemicarbazide (Tian
et al., 1995) and a-alanine (Nakao et al., 1966).
Herein, we report the synthesis and spectroscopic charac-
terization of a novel Schiff base ligand, H2L derived from
the condensation of 1,8-diaminonaphthalene and glyoxalic
acid and its Co(II), Ni(II), Cu(II) and Zn(II) complexes fol-
lowed by their in vitro antimicrobial screening against different
species of bacteria and fungi.
2. Experimental
2.1. Material and methods
All the reagents used were of A.R. grade. The metal salts
M(NO3)2Æ6H2O [M= Co(II), Ni(II), Zn(II); n= 6, Cu(II);
n= 3] and the chemical 1, 8-diaminonaphthalene and glyoxa-
lic acid (All E. Merck) were commerically pure samples used as
received.
2.2. Synthesis of Schiff base ligand, H2L
To a stirring methanolic solution (25 ml) of 1,8-diaminonaph-
thalene (1 mmol; 0.158 g), methanolic solution (25 ml) of gly-
oxalic acid (2 mmol, 0.22 ml) was added gradually. The
reaction mixture was magnetically stirred for 24 h at room
temperature, leading to the isolation of yellow solid product
which was ﬁltered, washed with methanol and dried in vacuum
over anhydrous calcium chloride.
2.3. Synthesis of complexes, [ML] [M= Co(II), Ni(II),
Cu(II), Zn(II)]
To a solution of metal nitrate (1 mmol) dissolved in 10 ml
methanol, methanolic solutions of both 1,8-diaminonaphtha-
lene (1 mmol, 0.158 g) and glyoxalic acid (2 mmol, 0.22 ml)
were added simultaneously under stirring. The stirring of reac-
tion mixture was continued for 24 h at room temperature,
leading to the isolation of coloured solid product which was ﬁl-
tered, washed with methanol and ﬁnally dried in vacuum over
anhydrous calcium chloride.
2.4. Physical measurements
The elemental analysis was made using Perkin–Elmer 2400
CHN elemental analyser. The FT-IR spectra (4000–200 cm1)
were recorded as KBr pellets on Perkin Elmer-2400 spectrome-
ter. 1H and 13C NMR spectra at room temperature were re-
corded in DMSO-d6 using Bruker Avance II 400 NMR
spectrophotometer. EPR spectrum was recorded on E112
ESR spectrometer at room temperature. TheFAB-Mass spectra
were recorded on Joel SX-102mass spectrometer. The electronic
spectra in DMSO were recorded on Pye-unicam-8800 spectro-
photometer at room temperature. Magnetic susceptibility mea-
surements were carried out on a Faraday balance at 25 C. The
electrical conductivities of 103 solution in DMSO were ob-
tained on a systronic type 302 Conductivity bridge equilibrated
Table 1 Antibacterial activity of H2L and its [ML] complexes.
Compounds Corresponding eﬀect on microorganism
Gram positive bacteria Gram negative bacteria
S. mutans S. Pyogenes MRSA* P. aeruginosa S. typhimurium E. coli
[H2L] 10.2 ± 0.3 11.9 ± 0.5 16.9 ± 0.3 11.2 ± 0.2 15.2 ± 0.4 12.3 ± 0.5
[CoL] 14.2 ± 0.3 12.9 ± 0.5 17.9 ± 0.3 13.2 ± 0.2 19.2 ± 0.4 15.2 ± 0.4
[NiL] 12 ± 0.5 10 ± 0.5 9.1 ± 0.3 13.2 ± 0.5 11.1 ± 0 15.2 ± 0.9
[CuL] 22 ± 0.5 21 ± 0.5 20 ± 0.2 17.5 ± 0.5 16.5 ± 0.5 20 ± 0.5
[ZnL] 13.1 ± 0.3 11.1 ± 0.5 14.3 ± 0.6 10.3 ± 0.6 17.8 ± 0.4 13.4 ± 0.5
Chloramp. 26.8 ± 0.5 22.4 ± 0.4 21 ± 0.5 17.1 ± 0.2 25.2 ± 0.8 20 ± 0.2
DMSO – – – – – –
* Methicillin resistant Staphylococcus aureus.
Table 2 Minimum inhibition concentration (MIC), [H2L] and its [ML] complexes, positive control chloramphenicol.
MIC (lg/ml) Strains [H2L] [CoL] [NiL] [CuL] [ZnL] Positive control
S. mutans 100 50 100 25 100 32
S. pyogenes 100 25 100 25 50 32
MRSA* 50 35 50 32 100 32
P. aeruginosa 50 25 50 25 50 32
S. typhimurium 50 25 50 25 50 32
E. coli 100 50 50 25 100 32
* Methicillin resistant Staphylococcus aureus (MRSA+ Ve).
Table 3 Antifungal activity of H2L and its [ML] complexes.
Compounds Corresponding eﬀect on microorganism
CA CK CP CN
[H2L] 15.5 ± 0.4 13.3 ± 1.2 11.1 ± 0.4 10.2 ± 0.2
[CoL] 15.5 ± 0.4 14.4 ± 1.2 12.1 ± 0.4 11.2 ± 0.2
[NiL] 12.2 ± 0.3 11.5 ± 0.3 10.2 ± 1.2 8.9 ± 0.5
[CuL] 18.5 ± 0.5 18.3 ± 1.2 16.8 ± 0.2 13.7 ± 0.5
[ZnL] 16.1 ± 0.5 17.5 ± 0.2 14.9 ± 0.7 11.1 ± 0.5
Fluconazole 20 ± 0.5 20 ± 0.5 18 ± 0.5 19 ± 0.5
DMSO – – – –
CA, Candida albicans; CK, Candida krusei; CP, Candida parapsilosis; CN, Cryptococcus neoformans.
Positive control (ﬂuconazole), and Negative control (DMSO) measured by the Halo Zone Test (Unit, mm).
Table 4 Minimum inhibition concentration (MIC), [H2L] and its [ML] complexes, positive control ﬂuconazole.
Strains H2L [CoL] [NiL] [CuL] [ZnL] Positive Control
Candida albicans 100 25 100 25 32 1
Candida krusei 100 50 100 25 32 64
Candida parpsilosis 100 50 100 25 64 8
Cryptococcus neoformans 100 50 50 25 50 8
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antimicrobial activity by disk diffusion assay with slight modiﬁ-
cations against some Gram-positive, Gram-negative strains of
bacteria and some fungi. After thatminimum inhibitory concen-
tration (MIC) of the complexes was determined.
2.5. Organism culture and in- vitro screening
Antibacterial activity of ligand H2L and its Co(II), Ni(II),
Cu(II) and Zn(II) complexes were completed by the disc diffu-
sion method with slight alterations. Inoculums of Streptococ-cus mutans, Pseudomonas aeruginosa, Methicillin resistant
Staphylococcus aureus (MRSA+ Ve), Staphylococcus pyoge-
nes, Salmonella typhimurium, and Escherichia coli were pre-
pared in BHI medium and incubated for 18 h at 37 C.
Subsequently a suspension of about 105 cfu mL1 was pre-
pared in autoclaved saline solution according to the McFar-
land protocol. Then 10 lL of this saline suspension was
mixed with10 mL of sterile antibiotic agar at 40 C and then
9 cm diameter plates were poured in a laminar ﬂow cabinet.
Five paper discs of 6.0 mm diameter were placed on these
nutrient agar plates. One milligrams of each test compound
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Scheme 2 Synthesis and proposed structure of Schiff base
complexes.
338 S.I. Al-Resayes et al.was dissolved in 100 ll DMSO to get ready stock solution and
from this stock solution varied concentrations 10, 20, 25, 50,
and 100 lg/ll of the trial compound were set. Subsequently
the compound of varied concentrations was poured over disc
plate onto it. The disc of chloramphenicol (30 lg) was used
as a positive control and DMSO poured disc as a negative con-
trol. The susceptibility was assessed on the basis of diameter of
zone of inhibition against Gram-positive and Gram-negative
strains of bacteria and fungi. The Zone of inhibition (mm) of
the ligand, H2L and its Co(II), Ni(II), Cu(II) and Zn(II) com-
plexes against Gram-positive and Gram-negative strains of
bacteria are shown in Table 1. The macro dilution test with
standard inoculums of 105 cfu mL1 was used to assess the
minimum inhibitory concentration (MIC) of test ligand and
its complexes. First of all, the ligand and its complexes were
dissolved in dimethyl sulfoxide (DMSO) then serial dilutions
of the test compounds were prepared to ﬁnal concentrations
of 512, 256, 128, 64, 32, 16, 8, 4, 2 and 1 mg/mL to all tube
was added 100 mL of a 24 h old inoculums. The MIC is the
lowest concentration of the trial compound, which can control
the visible growth after 18 h incubation at 37 C. The MIC was
determined visually after incubation for 18 h, at 37 C. After
18 h of incubation at 37 C MIC results for bacterial strains
are shown in table 2. For assaying antifungal activity, Candida
albicans, Candida krusie, Candida parapsilosis and Cryptococ-
cus neoformans were inoculated in Sabouraud Dextrose broth
medium (Hi-Media Mumbai) and incubated for 24 h at
35 C, and subsequently a suspension of about 106 cfu mL1
was prepared in sterile saline solution according to the McFar-
land protocol. Autoclaved Sabouraud Dextrose Agar (SDA)was poured onto 9 cm diameter plates in laminar ﬂow cabinet
and then with the help of sterilized cotton swabs the suspen-
sion of each fungal cell was streaked onto Sabouraud Dextrose
Agar (SDA) plates. Five paper discs of 6.0 mm diameter were
put onto Sabouraud Dextrose agar plate. 1 mg of test com-
pounds was dissolved in 100 ll DMSO to get ready stock solu-
tion and from this stock solution varied concentrations 10, 20,
25, 50, and 100 lg/ll of the trial compound were set. Subse-
quently the compound of varied concentrations was poured
over disc plate onto it. The disc of ﬂuconazole (30 lg) was
use as a positive control and DMSO poured disk as a negative
control. The susceptibility of different fungal strains against
test compounds was assessed on the basis of diameter of zone
of inhibition after 48 h of incubation at 35 C Table 3. MIC
results for fungal strains are shown in Table 4. The in vitro
antifungal activity assay showed that [CuL] complex was
more active antifungal than H2L and [ML] [M = Co(II),
Ni(II) and Zn(II)].
3. Results and discussion
Schiff base ligand, H2L was synthesized by the condensation
of 1,8-diaminonaphthalene and glyoxalic acid in 1:2 M ratio
Table 5 Analytical and physical data of Schiff base ligand and its metal complexes.
Compound Empirical formula Analysis found (calc.) Yield
(%)
Colour MP (C) Molar conductance
(X1 cm2 mol1)
m/z found
(Calcd.)
C H N
H2L C14H10N2O4 65.59(65.00) 4.45(4.65) 12.9(12.14) 25 Yellow >300 – 270 (270.4)
[CoL] C14H8N2O4Co 51.24(51.44) 2.23(2.46) 8.11(8.50) 70 Pink >300 12 326 (326.9)
[NiL] C14H8N2O4Ni 51.33(51.43) 2.14(2.46) 8.01(8.57) 76 Green >300 13 326 (326.6)
[CuL] C14H8N2O4Cu 50.14(50.68) 2.07(2.43) 8.08(8.28) 75 Dark green >300 11 331 (331.5)
[ZnL] C14H8N2O4Zn 50.33(50.40) 2.16(2.41) 7.99(8.17) 83 Oﬀ white >300 09 333 (333.2)
Synthesis, spectroscopic characterization and in vitro antimicrobial studies of Schiff base ligand 339dissolved in methanol (Scheme 1). The metal complexes were
synthesized by template procedure {in the view of very less
yield (33%) of ligand required for direct metallation with li-
gand} in 1:2:1 M ratio in methanol (Scheme 2). All complexes
were stable at room temperature and soluble in DMSO. The
formation of Schiff base ligand and its complexes was con-Table 6 IR spectral data (cm1) for schiff base ligand and its
complexes.
Compounds m(C‚N) m(CO2
)asym m(CO2
)sym m(M–N) m(M–O)
[H2L] 1635 1664 – – –
[CoL] 1607 1632 1376 553 478
[NiL] 1602 1628 1383 567 474
[CuL] 1590 1628 1371 570 473
[ZnL] 1607 1628 1378 573 447
Figure 1 The 1H NMRﬁrmed on the basis of results of elemental analysis, molecular
ion peak in mass spectra, the characteristic bands in the FT-IR
and resonance signals in the 1H NMR and 13C NMR spectra.
The overall geometry of the complexes was inferred from the
observed values of magnetic moments and the position of
the bands in the electronic spectra. The molar conductance
measurements of all the complexes recorded in DMSO, exhib-
ited their non electrolytic nature. All efforts failed to grow sin-
gle crystal suitable for X-ray crystallography. The analytical
data along with some physico-chemical properties of Schiff
base ligand and complexes are summarized in Table 5.
3.1. Infrared spectra
The prominent bands observed in the IR spectra of Schiff base
ligand, H2L and its complexes are listed in Table 6. Thespectrum of ligand.
340 S.I. Al-Resayes et al.spectrum of free ligand shows a strong band at 1635 cm1 as-
signed to m(C‚N), indicating the formation of desired Schiff
base ligand. This band undergoes negative shift of 30 cm1
on complexation indicating the involvement of azomethine
nitrogen in chelation with metal ions in the complexes (Singh
and Srivastava, 1988). This was further conﬁrmed by the pres-
ence of a new band observed in 440–460 cm1 region assigned
to m(M–N) (Ferraro, 1971). The intense band at 1664 cm1
present in the IR spectrum of free ligand may be assigned to
m(C‚O) of the carboxylic acid. However, this band was found
to be absent in all the complexes. Instead, IR spectra of all
complexes exhibit two bands at 1615–1635 cm1 and 1370–
1400 cm1 regions attributed to masym (CO2
) and msym
(CO2
) vibrations, respectively, indicating the involvement of
the carboxylate oxygen atom in coordination to the metal
ion. It is to be noted that D value [D= masym
(COO)  msym(COO)] is larger than 200 cm1 in all com-
plexes indicating the monodentate coordination of the COO
group to the metal ion (Deacon and Phillips, 1980) which is
further conﬁrmed by the presence of new band at 430–
480 cm1 assignable to m(M–O) (Ferraro, 1971).
3.2. 1H NMR and 13C NMR spectra
The formation of Schiff base ligand, H2L was further sup-
ported by the 1H NMR spectral study. The 1H NMR spectrum
of free ligand, H2L (Fig. 1) showed a resonance signals at 9.92
and 8.13 ppm assigned to carboxylic and azomethine protonsFigure 2 The 1H NMR speof proposed Schiff base moiety, respectively. The spectrum
of free ligand, exhibited a multiplet in 6.30–7.50 ppm region
which may be assigned to naphthalene protons (Jeong et al.,
2007). However the resonance signal assigned to carboxylic
protons in free ligand disappeared in the 1H NMR spectrum
of Zn(II) complex (Fig. 2) indicating the deprotonation of
carboxylic proton and the involvement of oxygen of carboxyl-
ate ion in chelation (Garg et al., 2002). However, the position
of resonance signals for azomethine proton and the aromatic
protons undergo a slight downﬁeld shift and appeared at
8.50 and 6.52–7.62 ppm, respectively on complexation with
Zn(II) ion (Hage et al., 1988; Krishnapriya and Kandaswamy,
2005).
The 13C NMR spectrum of Zn(II) complex revealed the
presence of expected number of signals corresponding to the
different types of carbon atoms. A strong NMR signal appear-
ing at 161 ppm (Shakir et al., 2009) may reasonably be to azo-
methine carbon and other at 194 ppm (Geeta et al., 2010)
assigned to carboxylate carbon COO. The chemical shifts
of naphthalene carbons appear at 138, 129, 127, 125, 123
and 120 ppm. These values were found to be downﬁeld shifted
by about 1.0–2.0 ppm as compared with free ligand (Shakir
et al., 2009).
3.3. Electronic spectra and magnetic moment
The electronic spectrum of Co(II) complex showed bands at
17,064 cm1 and 22,779 cm1. The band at 22,779 cm1 wasctrum of Zn(II) complex.
Figure 3 The EPR spectrum of Cu(II) complex.
Figure 4 The FAB mass spectrum of ligand.
Figure 5 The FAB mass spectrum of Ni(II) complex.
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342 S.I. Al-Resayes et al.assigned to pﬁ p* transitions, suggesting a square planar
environment around Co(II) ion which was further supported
by its magnetic moment value of 1.76 B.M. (Manhas et al.,
1995; Loginova et al., 2008). The electronic spectrum of Ni(II)
complex showed band at 28,260 cm1 which may be assigned
to charge transfer and other band at 22,280 cm1 single d-d
band is assigned to 1A2g‹ 1A1g transition (Lever, 1984).
The electronic spectrum of Cu(II) complex displays two bands
at 16,000 cm1 and 18,000 cm1 which may reasonably be as-
signed to 2A1g‹ 2B1g and 2Eg‹ 2B1g transitions, respectively,
consistent with a square planar geometry around Cu(II) ion
which is further conﬁrmed by its magnetic moment value of
1.82 B.M (Figgis, 1966).3.4. EPR spectrum
EPR spectrum of polycrystalline Cu(II) complex (Fig. 3) has
been recorded at room temperature. The absence of hyperﬁne
signal may be attributed to the strong dipolar and exchange
interaction between Cu(II) ions in the unit cell (Ahuja and Tri-
pathi, 1991). The calculated g|| = 2.21 and g^= 2.05 values
reasonably support that the 2B1 is the ground state having
an unpaired electron in the dx2–y2 orbital (Balhahausen,
1962). The g|| > g^ (2.32 > 2.05) suggests a square planar
environment around Cu(II) ion (Ottaviani et al., 1994; Kivel-
son and Neiman, 1961). The G parameter G= (g||  2)/
(g^  2) which measures the exchange interaction between
the metal centres in polycrystalline solid has been calculated.
According to Hathway if G> 4, the exchange interaction is
negligible and if G< 4 considerable exchange interaction oc-
curs in the solid complex in the complex (Hathaway et al.,
1971). The G value is greater than 4 indicating the exchange
interaction is negligible.3.5. FAB mass spectroscopy
The FAB-mass spectrum of Schiff base ligand, [H2L] (Fig. 4)
showed a molecular ion peak [M]+ at m/z 270 which corre-
sponds to its proposed molecular formula. The molecular ion
peaks for the schiff base complexes, [ML] [M = Co(II), Ni(II),
Cu(II) and Zn(II)] appear at m/z 326, 326, 331 and 333, respec-
tively, consistent with the proposed molecular formulae of the
complexes. A reference spectrum of [NiL] has been shown in
Fig. 5.3.6. In vitro antimicrobial activity
The in vitro antibacterial and antifungal activity of ligand
[H2L] and its complexes type, [ML], [M = Co(II), Ni(II),
Cu(II) and Zn(II)], were tested using the bacterial cultures of
S. mutans, P. aeruginosa, Methicillin resistant Staphylococcus
aureus (MRSA+ Ve), S. pyogenes, S. typhimurium, E. coli
and fungal cultures of C. albicans, Candida krusei, C. parapsi-
losis and C. neoformans, by the disc diffusion method (Khan
et al., 2007) and then the minimum inhibitory concentration
(MIC) of the ligand and complexes was determined. Chloram-
phenicol (30 lg) was used as positive control in case of bacte-
rial strains and in case of fungi; ﬂuconazole was used as a
positive control. While the disk poured in DMSO was used
as negative control. The minimum inhibitory concentration(MIC) was assessed by the macro dilution test using standard
inoculums of 105 cfu mL1. Initially the compounds were dis-
solved in dimethyl sulfoxide (DMSO) after that serial dilution
of the test compound was set to ﬁnal concentrations of 512,
256, 128, 64, 32, 16, 8, 4, 2 and 1 mg/mL to each tube was
added 100 mL of 24 h old inoculums. The MIC is the lowest
concentration of the test compound, which can restrain the
apparent growth after 18 h incubation at 37 C. The MIC
was determined visually after incubation for 18 h, at 37 C.
The in vitro study results veriﬁed that the Cu(II) complex
was found to be more active antimicrobial agent than ligand
H2L and Co(II), Ni(II) Zn(II) complexes. Zone of inhibition
was visualized after 18 h of incubation at 37 C. The suscepti-
bility was assessed on the basis of diameter of zone of inhibi-
tion against Gram-positive and Gram-negative strains of
bacteria and fungi. The zones of inhibition (mm) of ligand
and its complexes against Gram-positive and Gram-negative
strains of bacteria are shown in Table 3. Zones of inhibition
for fungal strains are shown in Table 3. MIC results for bacte-
rial strains are shown in Table 2 and for fungal strains in
Table 4.
The higher antimicrobial activity of the metal complexes as
compared to Schiff base ligand may be explained in terms of
chelation which makes metal complexes to act as more power-
ful and potent antimicrobial agents, thus inhibiting the growth
of the microorganisms (Berejo et al., 1999; Chohan et al.,
2003). Moreover, coordination reduces the polarity of the me-
tal ion mainly because of the partial sharing of its positive
charge with the donor groups within the chelate ring system.
This process, in turn, increases the lipophilic nature of the cen-
tral metal atom, which favours its permeation more efﬁciently
through the lipid layer of the microorganism, thus destroying
them more aggressively.
The Cu(II) complex showed enhanced activity. The distinct
difference in the antimicrobial property of compound further
justiﬁes the purpose of this study. The importance of such
work lies in the possibility that the new compound might be
more effective against bacteria for which a thorough investiga-
tion regarding the structure activity relationship, toxicity and
in their biological effects which would be helpful in designing
more potent antibacterial agents for therapeutic use if
required.
4. Conclusion
A Schiff base ligand, H2L derived from the condensation of 1,8
diaminonaphthalene and glyoxalic acid was synthesized and
characterized. The metal complexes with Co(II), Ni(II), Cu(II)
and Zn(II) ions were prepared by the template synthesis due to
very poor yield of ligand. The bonding of the ligand in the
complexes and the overall geometry have been deduced on
the basis of various spectroscopic techniques. The comparative
in vitro antimicrobial results suggested that the Cu(II) complex
shows a signiﬁcant antimicrobial activity as compared to
ligand, H2L and its Co(II), Ni(II) and Zn(II) complexes.Acknowledgement
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